Back
Enlivex Therapeutics Ltd. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
41
ENLV
Enlivex Therapeutics Ltd.
Last Price:
$1.01
Seasonality Move:
0.75%
7 Day Trial
ALL ACCESS PASS
$
7
-
The current trend is moderately bullish and ENLV is experiencing selling pressure, which indicates risk of future bearish movement.
Enlivex Therapeutics Ltd. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.12 | Sell |
| 20-day SMA: | 1.11 | Sell |
| 50-day SMA: | 0.98 | Buy |
| 200-day SMA: | 1.07 | Sell |
| 8-day EMA: | 1.08 | Sell |
| 20-day EMA: | 0.86 | Buy |
| 50-day EMA: | 0.5 | Buy |
| 200-day EMA: | 0.15 | Buy |
Enlivex Therapeutics Ltd. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.26 | Buy |
| Relative Strength Index (14 RSI): | 48.8 | Sell |
| Chaikin Money Flow: | -150984 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1 - 1.16) | Sell |
| Bollinger Bands (100): | (0.89 - 1.13) | Buy |
Enlivex Therapeutics Ltd. Technical Analysis
| Feb 5 | Feb 6 | Feb 9 | Feb 10 | Feb 11 | Feb 12 | Feb 13 | Feb 17 | Feb 18 | Feb 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb | ||||||||||
| 05 | 06 | 09 | 10 | 11 | 12 | 13 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Enlivex Therapeutics Ltd. Stock
Is Enlivex Therapeutics Ltd. Stock a Buy?
-
Enlivex Therapeutics Ltd. share price is 1.05 while ENLV 8-day simple moving average is 1.12, which is a Sell signal.
-
The stock price of ENLV is 1.05 while Enlivex Therapeutics Ltd. 20-day SMA is 1.11, which makes it a Sell.
-
Enlivex Therapeutics Ltd. 50-day simple moving average is 0.98 while ENLV share price is 1.05, making it a Buy technically.
-
ENLV stock price is 1.05 and Enlivex Therapeutics Ltd. 200-day simple moving average is 1.07, creating a Sell signal.
ENLV Technical Analysis vs Fundamental Analysis
Sell
41
Enlivex Therapeutics Ltd. (ENLV)
is a Sell
Is Enlivex Therapeutics Ltd. a Buy or a Sell?
-
Enlivex Therapeutics Ltd. stock is rated a SellThe current Enlivex Therapeutics Ltd. [ENLV] share price is $1.05. The Score for ENLV is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
Enlivex Therapeutics Ltd. Stock Info
Market Cap:
249.3M
Price in USD:
1.05
Share Volume:
151K
Enlivex Therapeutics Ltd. 52-Week Range
52-Week High:
2.10
52-Week Low:
0.66
Sell
41
Enlivex Therapeutics Ltd. (ENLV)
is a Sell
Enlivex Therapeutics Ltd. Share Price Forecast
-
What is the Enlivex Therapeutics Ltd. stock price today?The Enlivex Therapeutics Ltd. stock price is 1.05 USD today.
-
Will ENLV stock go up or go down?Enlivex Therapeutics Ltd.> share price is forecast to RISE/FALL based on technical indicators
-
Is Enlivex Therapeutics Ltd. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Enlivex Therapeutics Ltd. is overvalued.
Is Enlivex Therapeutics Ltd. Stock a Buy?
-
Enlivex Therapeutics Ltd. share price is 1.05 while ENLV 8-day exponential moving average is 1.08, which is a Sell signal.
-
The stock price of ENLV is 1.05 while Enlivex Therapeutics Ltd. 20-day EMA is 0.86, which makes it a Buy.
-
Enlivex Therapeutics Ltd. 50-day exponential moving average is 0.50 while ENLV share price is 1.05, making it a Buy technically.
-
ENLV stock price is 1.05 and Enlivex Therapeutics Ltd. 200-day simple moving average is 0.15, creating a Buy signal.
Fundamental Analysis of Enlivex Therapeutics Ltd.
Is Enlivex Therapeutics Ltd. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.08 per share, and a decrease next year of $0.46 per share.
Technical Analysis of Enlivex Therapeutics Ltd.
Should I short Enlivex Therapeutics Ltd. stock?
-
ENLV Moving Average Covergence Divergence (MACD) indicator is 0.26, suggesting Enlivex Therapeutics Ltd. is a Buy
-
Enlivex Therapeutics Ltd. Relative Strength Index (RSI) is 48.8, which suggest Enlivex Therapeutics Ltd. is oversold
-
The Bollinger Bands (25) for Enlivex Therapeutics Ltd. is (1 - 1.16), which suggest Enlivex Therapeutics Ltd. is a Buy
-
The Bollinger Bands (100) for Enlivex Therapeutics Ltd. is (0.89 - 1.13), which suggest Enlivex Therapeutics Ltd. is a Buy
* Enlivex Therapeutics Ltd. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.